• Home
  • About
  • The MDT
  • Science & innovation
    • New Therapies
    • Learning
    • Research & Clinical Trials
  • News & features
    • Features
    • News & Updates
  • Publications
    • General Publications
    • Clinical Guidelines
    • Patient Guidelines
  • Events
  • Contact
National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK
National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK

National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK

  • X
  • LinkedIn
  • Instagram
  • Home
  • About
  • The MDT
  • Science & innovation
    • New Therapies
    • Learning
    • Research & Clinical Trials
  • News & features
    • Features
    • News & Updates
  • Publications
    • General Publications
    • Clinical Guidelines
    • Patient Guidelines
  • Events
  • Contact

General Publications

General Publications

NHP 2023/2024 Annual Report

Posted 21st November 2024

Posted 6 months ago

By NHP Office

General Publications News & Updates Publications

NHP 2023/2024 Annual Report

The NHP activity report for 2023/2024 (published 21 November 2024) gives an overview of its core and partner-related activities.

Read More
New NHP Chair Announced – Dr Kate Gardner

Posted 19th November 2024

Posted 6 months ago

By NHP Office

Features General Publications News & Updates Publications

New NHP Chair Announced – Dr Kate Gardner

Following the stepping down of Professor Baba Inusa, Dr Kate Gardner has been appointed the new NHP Chair.

Read More
NHS England on Oxbryta (Voxelotor) Withdrawal From the UK Market

Posted 4th October 2024

Posted 8 months ago

By NHS England

General Publications New Therapies Publications

NHS England on Oxbryta (Voxelotor) Withdrawal From the UK Market

NHS England sends a letter to centres regarding the 25.09.2024 withdrawal of Pfizer's Oxbryta (Voxelotor) drug for Sickle Cell Disorder.

Read More
World Sickle Cell Day 2024

Posted 19th June 2024

Posted 11 months ago

By NHP Office

Features General Publications Publications

World Sickle Cell Day 2024

For World Sickle Cell Awareness Day (19th June) 2024, we ask; 'Why try to reinvent the wheel?'

Read More
International Thalassaemia Day 2024!

Posted 8th May 2024

Posted 1 year ago

By NHP Office

General Publications Publications

International Thalassaemia Day 2024!

A Call To Action

Read More
A Chapter Closes: Professor Baba Inusa Leaves the National Haemoglobinopathy Panel (NHP)

Posted 1st April 2024

Posted 1 year ago

By NHP Office

Features General Publications News & Updates Publications

A Chapter Closes: Professor Baba Inusa Leaves the National Haemoglobinopathy Panel (NHP)

The Founding Chair of the NHP, Professor Baba Inusa, announces his departure from the NHS and his NHP Role in March 2024.

Read More
NHP 2022/2023 Annual Report

Posted 21st January 2024

Posted 1 year ago

By NHP Office

General Publications Publications

NHP 2022/2023 Annual Report

The NHP Annual Report is a summary of its activities and interactions.

Read More

Quick links

Home
About
The MDT
Science & innovation
News & features
Events
Contact

Get in touch

The National Haemoglobinopathy Panel
Women’s and Children’s Academic Health - Kings College London
Becket House
1 Lambeth Palace Rd
London, SE1 7EU

Connect

  • X
  • LinkedIn
  • Instagram

  • NHP Haemoglobinopathy England
  • Sickle Cell Thalassaemia
  • Rare Inherited Anaemia UK

Website Design by Webfactory